A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer

By F. Khuri, J. Nemunaitis, I. Ganly, J. Arseneau, I. Tannock, L. Romel, M. Gore, J. Ironside, R. MacDougall, C. Heise and 6 more. Nature Medicine, 2000

1,158 citations recorded by the source corpus.

Subfields: Genetics, Molecular Biology, Oncology

View Paper: https://www.semanticscholar.org/paper/a28d6e4e122345bf6a11acfd47b06d8dea95ab5d

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Molecular Biology

1. F. McCormick
2. C. Sherr
3. J. Campisi
4. R. Weinberg
5. Annapoorni Rangarajan

In Oncology

1. F. McCormick
2. C. Sherr
3. R. Weinberg
4. J. Campisi
5. Annapoorni Rangarajan

Citations in the corpus

• The RB and p53 pathways in cancer. (2002, background): “, 2001), and more encouraging results of a phase II trial in combination with 5-fluorouracil and cysplatin have been reported (Khuri et al., 2000).”